SKI Market

Indian Indices

Nifty

25,879.15 3.35
(0.01%)

Sensex

84,478.67 12.16
( 0.01%)

Bank Nifty

58,381.95 107.30
( 0.18%)

Nifty IT

36,679.50 -175.90
( -0.48%)

Global Indices

Nasdaq

48,279.16 330.20
(0.69%)

Dow Jones

6,872.70 5.09
(0.07%)

Hang Seng

51,206.70 143.39
(0.28%)

Nikkei 225

9,816.37 -95.05
(-0.96%)

Forex

USD-INR

88.68 0.06
(0.07%)

EUR-INR

102.52 0.03
(0.03%)

GBP-INR

116.74 0.13
(0.11%)

JPY-INR

0.58 0.00
(-0.30%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Cipla Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500087

INE059A01026

411.5600262

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CIPLA

23.62

122773.15

EPS(TTM)

Face Value()

Div & Yield %

64.35

1.05

Back

Cipla consolidated net profit rises 3.73% in the September 2025 quarter

Oct 30,2025

Net profit of Cipla rose 3.73% to Rs 1351.17 crore in the quarter ended September 2025 as against Rs 1302.53 crore during the previous quarter ended September 2024. Sales rose 6.98% to Rs 7447.42 crore in the quarter ended September 2025 as against Rs 6961.22 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	7447.42	6961.22	7
OPM %	25.44	27.09	-
PBDT	2150.52	2060.80	4
PBT	1853.53	1789.06	4
NP	1351.17	1302.53	4

25,879.15 3.35 (0.01%)

84,478.67 12.16 ( 0.01%)

58,381.95 107.30 ( 0.18%)

36,679.50 -175.90 ( -0.48%)

48,279.16 330.20 (0.69%)

6,872.70 5.09 (0.07%)

51,206.70 143.39 (0.28%)

9,816.37 -95.05 (-0.96%)

88.68 0.06 (0.07%)

102.52 0.03 (0.03%)

116.74 0.13 (0.11%)

0.58 0.00 (-0.30%)